Early palliative care versus standard care in haematologic cancer patients at their last active treatment: study protocol of a feasibility trial

Silvia Tanzi, Stefano Luminari, Silvio Cavuto, Elena Turola, Luca Ghirotto, Massimo Costantini, Silvia Tanzi, Stefano Luminari, Silvio Cavuto, Elena Turola, Luca Ghirotto, Massimo Costantini

Abstract

Background: Patients with advanced haematological malignancies suffer from a very high symptom burden and psychological, spiritual, social and physical symptoms comparable with patients with metastatic non-haematological malignancy. Referral to palliative care services for these patients remains limited or often confined to the last days of life. We developed a palliative care intervention (PCI) integrated with standard haematological care. The aim of the study was focussed on exploring the feasibility of the intervention by patients, professionals and caregivers and on assessing its preliminary efficacy.

Methods/design: This is a mixed-methods phase 2 trial. The Specialist Palliative Care Team (SPCT) will follow each patient on a monthly basis in the outpatient clinic or will provide consultations during any hospital admission. SPCT and haematologists will discuss active patient issues to assure a team approach to the patient's care. This quantitative study is a monocentric parallel-group superiority trial with balanced randomisation comparing the experimental PCI plus haematological standard care versus haematological standard care alone. The primary endpoint will calculate on adherence to the planned PCI, measured as the percentage of patients randomised to the experimental arm who attend all the planned palliative care visits in the 24 weeks after randomisation. The qualitative study follows the methodological indications of concurrent nested design and was aimed at exploring the acceptability of the PCI from the point of view of patients, caregivers and physicians.

Discussion: In this trial, we will test the feasibility of an integrated palliative care approach starting when the haematologist decides to propose the last active treatment to the patient, according to his/her clinical judgement. We decided to test this criterion because it is able to intercept a wide range of patients'needs. The feasibility of this approach requires that we enrol at least 60 patients and that more than 50% of them be followed by the palliative care team for at least 24 weeks. The trial will include integrated qualitative data analysis; to give essential information on feasibility and acceptability.

Trial registration: ClinicalTrials.gov: NCT03743480 (November 16, 2018).

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart EPC-EMA 1

References

    1. Sepulveda C, Marlin A, Yoshida T, Ullrich A. Palliative care: the World Health Organization's global perspective. J Pain Symptom Manag. 2002;24:91–96. doi: 10.1016/S0885-3924(02)00440-2.
    1. World Health Organization . Cancer pain relief and palliative care. Technical Report Series 804. Geneva: WHO; 1990.
    1. Haun MW, Estel S, Rucker G, Friederich HC, Villalobos M, Thomas M, et al. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017;6:CD011129.
    1. Maltoni M, Scarpi E, Dall'Agata M, Schiavon S, Biasini C, Codeca C, et al. Systematic versus on-demand early palliative care: a randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. Eur J Cancer. 2016;69:110–118. doi: 10.1016/j.ejca.2016.10.004.
    1. Back AL, Park ER, Greer JA, Jackson VA, Jacobsen JC, Gallagher ER, et al. Clinician roles in early integrated palliative care for patients with advanced cancer: a qualitative study. J Palliat Med. 2014;17:1244–1248. doi: 10.1089/jpm.2014.0146.
    1. Zimmermann C, Swami N, Krzyzanowska M, Leighl N, Rydall A, Rodin G, et al. Perceptions of palliative care among patients with advanced cancer and their caregivers. CMAJ. 2016;188:E217–E227. doi: 10.1503/cmaj.151171.
    1. Costantini M, Apolone G, Tanzi S, Falco F, Rondini E, Guberti M, et al. Is early integration of palliative care feasible and acceptable for advanced respiratory and gastrointestinal cancer patients? A phase 2 mixed-methods study. Palliat Med. 2018;32:46–58. doi: 10.1177/0269216317731571.
    1. Sarradon-Eck A, Besle S, Troian J, Capodano G, Mancini J. Understanding the barriers to introducing early palliative care for patients with advanced cancer: a qualitative study. J Palliat Med. 2019;22:508–516. doi: 10.1089/jpm.2018.0338.
    1. Manitta V, Zordan R, Cole-Sinclair M, Nandurkar H, Philip J. The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manag. 2011;42:432–442. doi: 10.1016/j.jpainsymman.2010.12.008.
    1. LeBlanc TW, O'Donnell JD, Crowley-Matoka M, Rabow MW, Smith CB, White DB, et al. Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract. 2015;11:e230–e238. doi: 10.1200/JOP.2014.001859.
    1. LeBlanc TW, Smith JM, Currow DC. Symptom burden of haematological malignancies as death approaches in a community palliative care service: a retrospective cohort study of a consecutive case series. Lancet Haematol. 2015;2:e334–e338. doi: 10.1016/S2352-3026(15)00111-8.
    1. Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J, et al. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer. 2014;120:1572–1578. doi: 10.1002/cncr.28614.
    1. Howell DA, Shellens R, Roman E, Garry AC, Patmore R, Howard MR. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data. Palliat Med. 2011;25:630–641. doi: 10.1177/0269216310391692.
    1. Corbett CL, Johnstone M, Trauer JM, Spruyt O. Palliative care and hematological malignancies: increased referrals at a comprehensive cancer Centre. J Palliat Med. 2013;16:537–541. doi: 10.1089/jpm.2012.0377.
    1. Auret K, Bulsara C, Joske D. Australasian haematologist referral patterns to palliative care: lack of consensus on when and why. Intern Med J. 2003;33:566–571. doi: 10.1111/j.1445-5994.2003.00490.x.
    1. Bandieri E, Apolone G, Luppi M. Early palliative and supportive care in hematology wards. Leuk Res. 2013;37:725–726. doi: 10.1016/j.leukres.2013.03.007.
    1. Odejide OO, Cronin AM, Condron NB, Fletcher SA, Earle CC, Tulsky JA, et al. Barriers to quality end-of-life care for patients with blood cancers. J Clin Oncol. 2016;34:3126–3132. doi: 10.1200/JCO.2016.67.8177.
    1. Odejide OO, Cronin AM, Condron N, Earle CC, Wolfe J, Abel GA. Timeliness of end-of-life discussions for blood cancers: a national survey of hematologic oncologists. JAMA Intern Med. 2016;176:263–265. doi: 10.1001/jamainternmed.2015.6599.
    1. Manitta VJ, Philip JA, Cole-Sinclair MF. Palliative care and the hemato-oncological patient: can we live together? A review of the literature. J Palliat Med. 2010;13:1021–1025. doi: 10.1089/jpm.2009.0267.
    1. Tuca A, Gomez-Martinez M, Prat A. Predictive model of complexity in early palliative care: a cohort of advanced cancer patients (PALCOM study) Support Care Cancer. 2018;26:241–249. doi: 10.1007/s00520-017-3840-3.
    1. Barbaret C, Berthiller J, Pethelaz AMS, Michallet M, Salles G, Sanchez S, et al. Research protocol on early palliative care in patients with acute leukaemia after one relapse. BMJ Support Palliat Care. 2017;7:480–484. doi: 10.1136/bmjspcare-2016-001173.
    1. Roeland E, Ku G. Spanning the canyon between stem cell transplantation and palliative care. Hematology Am Soc Hematol Educ Program. 2015;2015:484–489. doi: 10.1182/asheducation-2015.1.484.
    1. Zimmermann C, Yuen D, Mischitelle A, Minden MD, Brandwein JM, Schimmer A, et al. Symptom burden and supportive care in patients with acute leukemia. Leuk Res. 2013;37:731–736. doi: 10.1016/j.leukres.2013.02.009.
    1. Loggers ET, LeBlanc TW, El-Jawahri A, Fihn J, Bumpus M, David J, et al. Pretransplantation supportive and palliative care consultation for high-risk hematopoietic cell transplantation patients. Biol Blood Marrow Transplant. 2016;22:1299–1305. doi: 10.1016/j.bbmt.2016.03.006.
    1. Bukki J, Scherbel J, Stiel S, Klein C, Meidenbauer N, Ostgathe C. Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review. Support Care Cancer. 2013;21:1743–1750. doi: 10.1007/s00520-013-1721-y.
    1. Porta-Sales J, Guerrero-Torrelles M, Moreno-Alonso D, Sarra-Escarre J, Clapes-Puig V, Trelis-Navarro J, et al. Is early palliative care feasible in patients with multiple myeloma? J Pain Symptom Manag. 2017;54:692–700. doi: 10.1016/j.jpainsymman.2017.04.012.
    1. El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, et al. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA. 2016;316:2094–2103. doi: 10.1001/jama.2016.16786.
    1. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321:694–696. doi: 10.1136/bmj.321.7262.694.
    1. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al. Designing and evaluating complex interventions to improve health care. BMJ. 2007;334:455–459. doi: 10.1136/.
    1. Creswell JW, Clark VL, Gutmann ML, Hanson WE. Advances in mixed methods research designs. In: Tashakkori A, Teddlie C, editors. Handbook of mixed methods in social and behavioral research. Thousand Oaks: Sage; 2003. pp. 209–240.
    1. Higginson IJ, Finlay IG, Goodwin DM, Hood K, Edwards AG, Cook A, et al. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers? J Pain Symptom Manag. 2003;25:150–168. doi: 10.1016/S0885-3924(02)00599-7.
    1. Costantini M, Rabitti E, Beccaro M, Fusco F, Peruselli C, La Ciura P, et al. Validity, reliability and responsiveness to change of the Italian palliative care outcome scale: a multicenter study of advanced cancer patients. BMC Palliat Care. 2016;15:23. doi: 10.1186/s12904-016-0095-6.
    1. Moro C, Brunelli C, Miccinesi G, Fallai M, Morino P, Piazza M, et al. Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer. 2006;14:30–37. doi: 10.1007/s00520-005-0834-3.
    1. Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, et al. Detecting psychological distress in cancer patients: validity of the Italian version of the hospital anxiety and depression scale. Support Care Cancer. 1999;7:121–127. doi: 10.1007/s005200050241.
    1. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5:649–655. doi: 10.1097/00000421-198212000-00014.
    1. Rubin HJ, Rubin I. Qualitative interviewing: the art of hearing data. 2. Thousand Oaks: Sage Publications; 2005.
    1. Taylor MC. Interviewing. In: Holloway I, editor. Qualitative research in health care. Maidenhead: McGraw-Hill Education; 2005. pp. 39–55.
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. doi: 10.1191/1478088706qp063oa.
    1. Payne S. Qualitative methods of data collection and analysis. In: Haddington-Hall JM, Bruera E, Higginson IJ, Payne S, editors. Research methods in palliative care. New York: Oxford University Press; 2007. pp. 139–160.
    1. Button E, Chan RJ, Chambers S, Butler J, Yates P. A systematic review of prognostic factors at the end of life for people with a hematological malignancy. BMC Cancer. 2017;17:213. doi: 10.1186/s12885-017-3207-7.
    1. Callaway MV, Connor SR, Foley KM. World health organization public health model: a roadmap for palliative care development. J Pain Symptom Manag. 2018;55:S6–13. doi: 10.1016/j.jpainsymman.2017.03.030.
    1. LeBlanc TW, Roeland EJ, El-Jawahri A. Early palliative care for patients with hematologic malignancies: is it really so difficult to achieve? Curr Hematol Malig Rep. 2017;12:300–308. doi: 10.1007/s11899-017-0392-z.
    1. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–742. doi: 10.1056/NEJMoa1000678.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren